Vivo Bio Tech Ltd — Board Meeting, 30-05-2026: Board Meeting

VIVO BIO TECH's board approved the financial results for the fourth quarter and year, reporting a consolidated net loss of Rs 5.16 Cr (Q4) and Rs 1.71 Cr (full-year). The board also greenlit re-appointing a director and an advisor for a potential scheme of arrangement.